摘要
经皮冠状动脉介入治疗(PCI)是冠心病重要的治疗方法,迄今已走过30余年,目前已成为与药物治疗、外科冠状动脉旁路移植手术并驾齐驱的治疗手段。经皮冠状动脉腔内成形术、裸金属支架置入技术、药物洗脱支架置入技术成为冠心病介入治疗的三个里程碑。特别是近期药物洗脱支架的应用拓宽了PCI的适应证,看到了战胜支架内再狭窄的曙光。
Percutaneous coronary intervention （PCI）has been used for more than 30 years as an important method for coronary heart disease therapy. It has become the therapy keeping pace with drug therapy and coronary artery bypass graft surgery （CABG） in surgery. Percutaneous transluminal coronary angioplasty （PTCA） ,bare-metal stem （BMS）and drug-eluting stent （DES） are the three milestones in interventional cardiology of coronary heart disease. And the use of drug-eluting stent recent years has broadened the indications of percutaneous coronary intervention （PCI） which makes us catch sight of the glimmer of hope in avoiding in-stent restenosis（ISR）.
出处
《医学综述》
2008年第16期2512-2516,共5页
Medical Recapitulate
关键词
冠心病
介入治疗
进展
Coronary heart disease
Interventional therapy
Advancement
